Return to homepagePandemic Pact

Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93019D00021-0-759302400002-2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2024
    2025

  • Known Financial Commitments (USD)

    $206,532

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    BRETT HURST

  • Research Location

    United States of America

  • Lead Research Institution

    UTAH STATE UNIVERSITY

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.